Back to today’s briefing

Story perspectives

Chemotherapy Boosts DNA Mutations, Raises Cancer Risk

7/2/2025

38 4

Summary

Story summary

In a groundbreaking study, Koichi Takahashi and his team uncovered that chemotherapy, especially melphalan, significantly increases DNA mutations in blood stem cells of multiple myeloma patients. This reduction in clonal diversity could heighten the risk of secondary cancers, paving the way for innovative preventive measures in cancer treatment.

1 of 1

Story summary

In a groundbreaking study, Koichi Takahashi and his team uncovered that chemotherapy, especially melphalan, significantly increases DNA mutations in blood stem cells of multiple myeloma patients. This reduction in clonal diversity could heighten the risk of secondary cancers, paving the way for innovative preventive measures in cancer treatment.